Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Camp4 Therapeutics (CAMP) Invested Capital (2023 - 2025)

Camp4 Therapeutics (CAMP) has disclosed Invested Capital for 3 consecutive years, with $47.7 million as the latest value for Q4 2025.

  • Quarterly Invested Capital fell 24.64% to $47.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47.7 million through Dec 2025, down 24.64% year-over-year, with the annual reading at $47.7 million for FY2025, 24.64% down from the prior year.
  • Invested Capital hit $47.7 million in Q4 2025 for Camp4 Therapeutics, down from $58.7 million in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $63.3 million in Q4 2024 to a low of -$159.0 million in Q3 2024.
  • Historically, Invested Capital has averaged -$41.5 million across 3 years, with a median of -$35.7 million in 2023.
  • Biggest YoY gain for Invested Capital was 151.16% in 2024; the steepest drop was 42.51% in 2024.
  • Year by year, Invested Capital stood at -$123.7 million in 2023, then soared by 151.16% to $63.3 million in 2024, then dropped by 24.64% to $47.7 million in 2025.
  • Business Quant data shows Invested Capital for CAMP at $47.7 million in Q4 2025, $58.7 million in Q3 2025, and $40.1 million in Q2 2025.